Activation of Canonical BMP4-SMAD7 Signaling Suppresses Breast Cancer Metastasis
- 13 March 2020
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 80 (6), 1304-1315
- https://doi.org/10.1158/0008-5472.can-19-0743
Abstract
Metastasis is the major cause of death in cancer patients; with no therapeutic cure, treatments remain largely palliative. As such, new targets and therapeutic strategies are urgently required. Here we show that bone morphogenetic protein-4 (BMP4) blocks metastasis in animal models of breast cancer and predicts improved survival in patients. In preclinical models of spontaneous metastasis, BMP4 acted as an autocrine mediator to modulate a range of known metastasis-regulating genes, including SMAD7, via activation of canonical BMP-SMAD signaling. Restored BMP4 expression, or therapeutically administered BMP4 protein, blocked metastasis and increased survival by sensitising cancer cells to anoikis, thereby reducing the number of circulating tumour cells. Gene silencing of BMP4, or its downstream mediator SMAD7, reversed this phenotype. Administration of recombinant BMP4 markedly reduced spontaneous metastasis to lung and bone. Elevated levels of BMP4 and SMAD7 were prognostic for improved recurrence-free survival and overall survival in breast cancer patients, indicating the importance of canonical BMP4 signaling in the suppression of metastasis and highlighting new avenues for therapy against metastatic disease.Other Versions
Funding Information
- NHMRC (APP400037, APP1121199)
- Peter MacCallum Cancer Centre Foundation
- Cancer Council Victoria (APP1006425)
This publication has 52 references indexed in Scilit:
- BreastMark: An Integrated Approach to Mining Publicly Available Transcriptomic Datasets Relating to Breast Cancer OutcomeBreast Cancer Research, 2013
- Identification of NOG as a Specific Breast Cancer Bone Metastasis-supporting GeneJournal of Biological Chemistry, 2012
- Analysis of BMP4 and BMP7 signaling in breast cancer cells unveils time-dependent transcription patterns and highlights a common synexpression group of genesBMC Medical Genomics, 2011
- Disruption of bone morphogenetic protein receptor 2 (BMPR2) in mammary tumors promotes metastases through cell autonomous and paracrine mediatorsProceedings of the National Academy of Sciences of the United States of America, 2011
- GOBO: Gene Expression-Based Outcome for Breast Cancer OnlinePLOS ONE, 2011
- Constitutive activation of BMP signalling abrogates experimental metastasis of OVCA429 cells via reduced cell adhesionJournal of Ovarian Research, 2010
- Learning therapeutic lessons from metastasis suppressor proteinsNature Reviews Cancer, 2009
- Conditional Deletion of Smad1 and Smad5 in Somatic Cells of Male and Female Gonads Leads to Metastatic Tumor Development in MiceMolecular and Cellular Biology, 2008
- A collection of breast cancer cell lines for the study of functionally distinct cancer subtypesCancer Cell, 2006
- Bone Morphogenetic ProteinsGrowth Factors, 2004